# 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma

> **NCT07038278** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 20 (estimated)

## Conditions studied

- Soft Tissue Sarcoma (STS)

## Interventions

- **DRUG:** 5-ALA

## Key facts

- **NCT ID:** NCT07038278
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038278, "5-AminoLevulinic Acid Aided Resection Margins in Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07038278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*